Christoph Von Amsterdam

Title: Christoph Von Amsterdam: Innovator in Medicinal Chemistry

Introduction

Christoph Von Amsterdam is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for anxiety disorders. With a total of 3 patents to his name, his work has the potential to impact many lives.

Latest Patents

His latest patents focus on the use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts. This compound is utilized in the manufacture of a medicament aimed at treating various sub-type anxiety disorders. These disorders include panic disorder with or without agoraphobia, obsessive-compulsive spectrum disorders, social phobia, posttraumatic stress disorder, acute stress indication, generalized anxiety disorder, bipolar disorders, mania, dementia, substance-related disorders, sexual dysfunctions, eating disorders, obesity, anorexia, and fibromyalgia. A preferred salt for this application is 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride.

Career Highlights

Christoph is currently employed at Merck Patent GmbH, where he continues to innovate in the field of pharmaceuticals. His work is characterized by a commitment to developing effective treatments for mental health conditions.

Collaborations

Throughout his career, Christoph has collaborated with esteemed colleagues such as Gerd Bartoszyk and Christoph Seyfried. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Christoph Von Amsterdam stands out as a dedicated inventor in the realm of medicinal chemistry. His innovative work in developing treatments for anxiety disorders showcases his commitment to improving mental health care.